Avalon Biodegradable Nitrile Exam Gloves

Brand GloveOn
Type Biodegradable range, Nitrile gloves
Quantity
200 gloves per box (XS-L), 180 gloves per box (XL), 10 boxes per carton
Sizes XS, S, M, L, XL
Product code BDG121
Product Data Sheet Download

Buy direct from Mun

SKU: BDG121 Categories: Aged Care/NDIS, Biodegradable, Dental, Exam Gloves, Food & Hospitality, General Practitioner, Hospital, Industrial, Laboratory, Nitrile Gloves, Veterinary

Description
Specifications

Help improve the environment with GloveOn Avalon biodegradable gloves. Designed to break down normal nitrile gloves in landfill settings, these gloves will take years rather than decades to completely biodegrade. Our unique formulation maintains the high levels of strength and flexibility you’d expect in a nitrile glove, while only allowing the biodegradation process to start once in landfill conditions. Feel confident that GloveOn Avalon will give you the protection you need and help you do your bit for the environment.

Features

Biodegrades in landfill conditions.
Fingertip textured.
Powder Free.
Not made with natural rubber latex.
Chemo drugs tested.
Lab chemical tested.
Ambidextrous.
Standard Cuff.
Violet blue colour.

Reorder code	Size
BDG121XS	X-Small
BDG121SS	Small
BDG121MM	Medium
BDG121LL	Large
BDG121XL	X-Large

Glove Properties	Measurement (mm)
Length	≥230
Thickness at Palm (centre of Palm)	0.07 ± 0.02
Thickness at Finger	0.10 ± 0.02

Physical Properties	Before Ageing	After Ageing
Tensile Strength (MPa)	≥18	≥16
Elongation (%)	≥500	≥400

Inspection Levels and AQL	Inspection Level	AQL
Watertightness	G1	1.5
Physical Dimensions	S2	4.0
Tensile Strength	S2	4.0
Visual Inspection (Major)	S4	2.5
Visual Inspection (Minor)	S4	4.0
Particulate Residue	N=5	≤2mg/glove

Packaging
Configuration	200 gloves per box for XS to L 180 gloves per box for XL 10 boxes per carton

Regulatory Compliance
Regulations	ARTG 164563 FDA 510(k) MDR 2017/745 REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 EU 2016/425

International Standards
Standards	ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 ASTM D5526 ASTM D5511 EN ISO 374-1 (Type C) EN 374 part 2, 4 & 5 EN 16523-1 EN 420 EN 455 part 1, 2, 3 EN 1186 EN 13130 CEN/TS 14234 ISO 10993 part 5, 10, 11 HACCP International Certified

Manufacturing Accreditations
Accreditations	ISO 9001 ISO 13485 EN ISO 13485

Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05-Test Report PN 145460)	Minimum Breakthrough Detection Time (minutes)
Carmustine (BCNU), 3.3mg/ml (3,300ppm)	22.2
Cisplatin, 1.0mg/ml (1,000ppm)	>240
Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm)	>240
Dacarbazine (DTIC), 10.0mg/ml (10,000ppm)	>240
Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm)	>240
Etoposide (Toposar), 20.0mg/ml (20,000ppm)	>240
Fluorouracil, 50.0mg/ml (50,000ppm)	>240
Methotrexate, 25.0mg/ml (25,000ppm)	>240
Mitomycin C, 0.5mg/ml (500ppm)	>240
Paclitaxel (Taxol), 6.0mg/ml (6,000ppm)	>240
Thiotepa, 10.0mg/ml (10,000ppm)	66.1
Vincristine Sulfate, 1.0mg/ml (1,000ppm)	>240
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Celeste nitrile glove at 22.2 minutes and 66.1 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.

Biodegrades in landfill conditions.
Fingertip textured.
Powder Free.
Not made with natural rubber latex.
Chemo drugs tested.
Lab chemical tested.
Ambidextrous.
Standard Cuff.
Violet blue colour.

Reorder code	Size
BDG121XS	X-Small
BDG121SS	Small
BDG121MM	Medium
BDG121LL	Large
BDG121XL	X-Large

Glove Properties	Measurement (mm)
Length	≥230
Thickness at Palm (centre of Palm)	0.07 ± 0.02
Thickness at Finger	0.10 ± 0.02

Physical Properties	Before Ageing	After Ageing
Tensile Strength (MPa)	≥18	≥16
Elongation (%)	≥500	≥400

Inspection Levels and AQL	Inspection Level	AQL
Watertightness	G1	1.5
Physical Dimensions	S2	4.0
Tensile Strength	S2	4.0
Visual Inspection (Major)	S4	2.5
Visual Inspection (Minor)	S4	4.0
Particulate Residue	N=5	≤2mg/glove

Packaging
Configuration	200 gloves per box for XS to L 180 gloves per box for XL 10 boxes per carton

Regulatory Compliance
Regulations	ARTG 164563 FDA 510(k) MDR 2017/745 REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 EU 2016/425

International Standards
Standards	ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 ASTM D5526 ASTM D5511 EN ISO 374-1 (Type C) EN 374 part 2, 4 & 5 EN 16523-1 EN 420 EN 455 part 1, 2, 3 EN 1186 EN 13130 CEN/TS 14234 ISO 10993 part 5, 10, 11 HACCP International Certified

Manufacturing Accreditations
Accreditations	ISO 9001 ISO 13485 EN ISO 13485

Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05-Test Report PN 145460)	Minimum Breakthrough Detection Time (minutes)
Carmustine (BCNU), 3.3mg/ml (3,300ppm)	22.2
Cisplatin, 1.0mg/ml (1,000ppm)	>240
Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm)	>240
Dacarbazine (DTIC), 10.0mg/ml (10,000ppm)	>240
Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm)	>240
Etoposide (Toposar), 20.0mg/ml (20,000ppm)	>240
Fluorouracil, 50.0mg/ml (50,000ppm)	>240
Methotrexate, 25.0mg/ml (25,000ppm)	>240
Mitomycin C, 0.5mg/ml (500ppm)	>240
Paclitaxel (Taxol), 6.0mg/ml (6,000ppm)	>240
Thiotepa, 10.0mg/ml (10,000ppm)	66.1
Vincristine Sulfate, 1.0mg/ml (1,000ppm)	>240
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Celeste nitrile glove at 22.2 minutes and 66.1 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.